Indications and uses
First aid to help prevent infection, and temporarily reliever pain and itching associated with minor cuts. scrapes and burn
3-Step First Aid Kit
- Manufacturer
- Swabplus Inc.
- Effective date
- 2013-03-18
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 11
- Source
- full-release
- Hydrated at
- 2026-05-31 22:34:56
Label at a glance#
Product3-Step First Aid Kit
Active ingredientLIDOCAINE HYDROCHLORIDE, Benzalkonium Chloride, Povidone-Iodine
Label structure10 sections
Dosage and administration
Do not use if label seal is broken prior to purchase. Hold the swab vertically, with the color ring band tip upwards. Hold in the center of the stem with one hand and at the color band with the other. Bend the tip at the color band to one side until it snaps. Apply the product to the affected area. Discard swab after use.
Label contents#
Full prescribing information#
Drug FactsActive Ingredients
Antiseptic Swabs
Lidocaine Hydrochloride 1.0%
Benzalkonium Chloride 0.11%
Povidone Iodine swabs:
Povidone Iodine 10%, equal to available Iodine 1% for antiseptic
Purpose
Lidocaine Hydrochloride for Pain Relief
Benzalkonium Chloride for Antiseptic
Povidone Iodine for Antiseptis
Uses
First aid to help prevent infection, and temporarily reliever pain and itching associated with minor cuts. scrapes and burn
Keep out of reach of children
Keeo out of reach of children
Directions
- Do not use if label seal is broken prior to purchase.
- Hold the swab vertically, with the color ring band tip upwards. Hold in the center of the stem with one hand and at the color band with the other.
- Bend the tip at the color band to one side until it snaps.
- Apply the product to the affected area.
- Discard swab after use.
Warnings
For external use only. Keep out of eyes. Non-Sterile. Discontinue use if irritation occurs. Do not insert inear canal. Keep at room temperture. Avoid direct sunlight.
Do not use. Swabs if you are sensitive to any product ingredients. in the eyes. longer than one week unless directed by a doctor.
Stop use and ask a doctor if you have deep or punchture wounds, or serious burns. redness, irritation, sweeling or pain continues or increases, infection occurs
Other information
For adult and children 2 and older: Clean affected area. Apply 1 to 3 times daily. May be covered with a bandage.
Children under 2 years of age: Consult a doctor.
Avoid storing at excessive heat.
Inactive Ingredients
Antiseptic swab: Dizolidinyl Urea, Methylparaben, Propylparaben, Water
Providone Iodine Swab: Glcerin, Water
Manufacturer Statement
Soft cotton tip swabs individually filled with Antiseptic or Iodine. Ready to use and convenient to carry for fast, clean, safe first aid.
Patented and manufactured by Swabplus Inc. Rancho Cucamonga, CA 91730 USA
The COLOR RING is copyrighted by Swabplus Inc. ©2007 SWABPLUS INC.
Package and label
Image of first aid carton label
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 797730 | povidone-iodine 10 % Medicated Pad | PSN | 11 |
| 797730 | povidone-iodine 100 MG/ML Medicated Pad | SCD | 11 |
| 797730 | povidone-iodine 10 % (titratable iodine 1 % ) Medicated Pad | SY | 11 |
| 797730 | povidone-iodine 10 % Medicated Pad | SY | 11 |
| 797730 | povidone-iodine 10 % Medicated Swabstick | SY | 11 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 65734-000-23 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0448-f424-e053-dadaa90a57ce | 3 Step First Aid Kit Medication Filled Swabs |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65734-000-23 | 3-Step First Aid Kit | 1 in 1 CARTON | KIT | 1 | 11 | |
| 65734-125-01 | 3-Step First Aid Kit | 2 mL in 1 PACKET | LIQUID | 2 mL | 11 mg in 10mL | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 65734-000 | 3-STEP FIRST AID KIT (POVIDONE-IODINE, LIDOCAINE HYDROCHLORIDE, BENZALKONIUM CHLORIDE) KIT [SWABPLUS INC.] | 11 | Legacy NDC, 2 package rows | 20130321_4f2dc3fe-9388-4a31-8eff-cfdb2d3501fb.zip |
| 65734-119 | 3-STEP FIRST AID KIT (POVIDONE-IODINE, LIDOCAINE HYDROCHLORIDE, BENZALKONIUM CHLORIDE) KIT [SWABPLUS INC.] | 11 | Unmatched | 20130321_4f2dc3fe-9388-4a31-8eff-cfdb2d3501fb.zip |
| 65734-125 | 3-STEP FIRST AID KIT (POVIDONE-IODINE, LIDOCAINE HYDROCHLORIDE, BENZALKONIUM CHLORIDE) KIT [SWABPLUS INC.] | 11 | Unmatched | 20130321_4f2dc3fe-9388-4a31-8eff-cfdb2d3501fb.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Benzalkonium Chloride | ACTIVE INGREDIENT | F5UM2KM3W7 | 11 | |
| LIDOCAINE HYDROCHLORIDE | ACTIVE INGREDIENT | V13007Z41A | 11 | |
| Povidone-Iodine | ACTIVE INGREDIENT | 85H0HZU99M | 11 | |
| BENZALKONIUM | ACTIVE MOIETY | 7N6JUD5X6Y | 11 | |
| Iodine | ACTIVE MOIETY | 9679TC07X4 | 11 | |
| LIDOCAINE | ACTIVE MOIETY | 98PI200987 | 11 | |
| Diazolidinyl Urea | INACTIVE INGREDIENT | H5RIZ3MPW4 | 11 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 11 | |
| Methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 11 | |
| Propylene Glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 11 | |
| Propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 11 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 11 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 11 |
Products#
Every source-derived product name is available through these pages.
- 3-Step First Aid Kit
- Povidone-Iodine, Lidocaine Hydrochloride, Benzalkonium Chloride
- Antiseptic and Anesthetic Swab
- Lidocaine Hydrochloride, Benzalkonium Chloride
- LIDOCAINE HYDROCHLORIDE
- LIDOCAINE
- LIDOCAINE HYDROCHLORIDE ANHYDROUS
- Benzalkonium Chloride
- BENZALKONIUM
- Water
- Diazolidinyl Urea
- Methylparaben
- Propylparaben
- Propylene Glycol
- Povidone-Iodine Swab
- Povidone-Iodine
- Iodine
- Sodium Hydroxide
- Glycerin
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 65734-000 | 65734-000-23 |
| 65734-125 | 65734-125-01 |
| 65734-119 | 65734-119-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LIDOCAINE HYDROCHLORIDE | V13007Z41A | ACTIR |
| Benzalkonium Chloride | F5UM2KM3W7 | ACTIB |
| Water | 059QF0KO0R | IACT |
| Diazolidinyl Urea | H5RIZ3MPW4 | IACT |
| Methylparaben | A2I8C7HI9T | IACT |
| Propylparaben | Z8IX2SC1OH | IACT |
| Propylene Glycol | 6DC9Q167V3 | IACT |
| Povidone-Iodine | 85H0HZU99M | ACTIM |
| Sodium Hydroxide | 55X04QC32I | IACT |
| Glycerin | PDC6A3C0OX | IACT |
| Water | 059QF0KO0R | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | CREAM / TOPICAL | 69 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / SOFT TISSUE | 0.02 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRATUMOR | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / EXTRACORPOREAL | ADJ PH | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | CREAM / VAGINAL | 22 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | OINTMENT, AUGMENTED / TOPICAL | 0.11 %w/w | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRADERMAL | ADJ PH | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | TABLET, COATED / ORAL | 0.8 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | TABLET, FILM COATED / ORAL | 8 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / RECTAL | 90400 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / SUBCUTANEOUS | 0.02 %w/v | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | ELIXIR / ORAL | 800 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | POWDER, FOR SOLUTION / ORAL | 13 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / TOPICAL | 8 %w/w | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAVENOUS | 456 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | GEL / VAGINAL | 8 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / RESPIRATORY (INHALATION) | 10 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / SUBCUTANEOUS | 0.16 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / AURICULAR (OTIC) | 10 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRATHECAL | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, DELAYED RELEASE / ORAL | 0.25 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / TOPICAL | 24 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 3.6 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SHAMPOO, SUSPENSION / TOPICAL | 0.15 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | OINTMENT / TOPICAL | 0.2 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / OPHTHALMIC | 1.5 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / SUBCUTANEOUS | 1.4 %w/v | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | DROPS / NASAL | 26 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAVASCULAR | ADJ PH | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / TOPICAL | 76000 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SHAMPOO / TOPICAL | 3 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRAVASCULAR | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / DENTAL | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | PASTE / DENTAL | 0.6 %w/w | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | DISC / TOPICAL | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAVITREAL | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRAVENOUS | 78 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / PARENTERAL | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / AURICULAR (OTIC) | 0.8 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | JELLY / TOPICAL | 180 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / SUBCUTANEOUS | 31.45 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | LIQUID / TOPICAL | 0.1 %w/w | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | DROPS / ORAL | 200 mg/1ml | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | FILM / BUCCAL | 0.09 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | OINTMENT / OPHTHALMIC | 0.05 %w/w | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | JELLY / TOPICAL | ADJ PH | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / SOFT TISSUE | 0.15 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | EMULSION / TOPICAL | 0.2 %w/w | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | ADJ PH | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / TOPICAL | 5148 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| fff42904-fe50-4b45-ab9b-87ba73b35328 | 4f2dc3fe-9388-4a31-8eff-cfdb2d3501fb | 2013-03-18 | Warnings | fff42904-fe50-4b45-ab9b-87ba73b35328 4f2dc3fe-9388-4a31-8eff-cfdb2d3501fb |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.